Pages that link to "Q43912920"
Jump to navigation
Jump to search
The following pages link to Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002. (Q43912920):
Displaying 50 items.
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies (Q30234647) (← links)
- Pharmacological maintenance treatments of opiate addiction (Q33582080) (← links)
- Accounting for individual differences and timing of events: estimating the effect of treatment on criminal convictions in heroin users (Q33693992) (← links)
- The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study (Q33739895) (← links)
- Characterizing longitudinal health state transitions among heroin, cocaine, and methamphetamine users. (Q33810775) (← links)
- Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response (Q33903933) (← links)
- Methadone treatments in a Swiss region, 2001-2008: a registry-based analysis (Q34523541) (← links)
- A randomized trial of oral naltrexone for treating opioid-dependent offenders (Q34581008) (← links)
- Characteristics and 9-month outcomes of discharged methadone maintenance clients (Q34674269) (← links)
- A day-by-day investigation of changes in criminal convictions before and after entering and leaving opioid maintenance treatment: a national cohort study. (Q35019120) (← links)
- Maintenance Treatment with Opium Tincture: A Preliminary Qualitative Study of the Factors Related to Treatment entry (Q35545123) (← links)
- Dynamics in the costs of criminality among opioid dependent individuals (Q35684512) (← links)
- Retention and HIV seroconversion among drug users on methadone maintenance treatment in Yunnan, China (Q35775665) (← links)
- Non-medical use of opioids among HIV-infected opioid dependent individuals on opioid maintenance treatment: the need for a more comprehensive approach (Q35777089) (← links)
- Investigation of Repeat Client Drop-Out and Re-Enrolment Cycles in Fourteen Methadone Maintenance Treatment Clinics in Guangdong, China (Q35814376) (← links)
- Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment (Q35856799) (← links)
- Evaluating the Effectiveness of First-Time Methadone Maintenance Therapy Across Northern, Rural, and Urban Regions of Ontario, Canada (Q36238800) (← links)
- The importance of blood-borne viruses in elevated cancer risk among opioid-dependent people: a population-based cohort study (Q36370353) (← links)
- ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics (Q36441533) (← links)
- Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN). (Q36628467) (← links)
- Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations (Q36750914) (← links)
- Characterizing durations of heroin abstinence in the California Civil Addict Program: results from a 33-year observational cohort study (Q36854061) (← links)
- Establishing the Melbourne Injecting Drug User Cohort Study (MIX): rationale, methods, and baseline and twelve-month follow-up results (Q36952990) (← links)
- Client and program factors associated with dropout from court mandated drug treatment. (Q37245110) (← links)
- One-year and cumulative retention as predictors of success in methadone maintenance treatment: a comparison of two clinics in the United States and Israel (Q37260362) (← links)
- Opioid replacement therapy: a wait unmanaged (Q37876957) (← links)
- Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study (Q38449882) (← links)
- Estimating met demand for alcohol and other drug treatment in Australia (Q38859987) (← links)
- The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California (Q39095973) (← links)
- Incarcerated intravenous heroin users: predictors of post-release utilization of methadone maintenance treatment. (Q39181057) (← links)
- Subsidising patient dispensing fees: the cost of injecting equity into the opioid pharmacotherapy maintenance system (Q39247401) (← links)
- “Should I stay or should I go?” Coming off methadone and buprenorphine treatment (Q39826431) (← links)
- A case study using a patient satisfaction survey to improve the delivery and effectiveness of drug addiction treatment services: marketing implications and organizational impact (Q40023436) (← links)
- Risk of mortality on and off methadone substitution treatment in primary care: a national cohort study. (Q40669150) (← links)
- Characterizing Long-Term Health Related Quality of Life Trajectories of Individuals With Opioid Use Disorder (Q42709317) (← links)
- A national study of a telephone support service for patients receiving office-based buprenorphine medication-assisted treatment: Study feasibility and sample description (Q42930559) (← links)
- Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study. (Q44330424) (← links)
- John or Jane? Exploring how clinical judgment is applied in managing access to opioid replacement therapy. (Q44341804) (← links)
- A comparative study of opioid substitution therapy utilisation among opioid-dependent men and women (Q44344923) (← links)
- How clinicians manage access to opioid replacement therapy (Q44345189) (← links)
- The State of Opioid Agonist Therapy in Canada 20 Years after Federal Oversight (Q44345763) (← links)
- Sexual dysfunction during methadone maintenance treatment and its influence on patient's life and treatment: a qualitative study in South China (Q45277209) (← links)
- Pharmacogenetics of Methadone Response (Q47425192) (← links)
- An 18-year follow-up of patients admitted to methadone treatment for the first time (Q51872493) (← links)
- Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention. (Q52305142) (← links)
- Methadone Dosage and Plasma Levels, SNPs of OPRM1 Gene and Age of First Drug Use Were Associated With Outcomes of Methadone Maintenance Treatment (Q58694808) (← links)
- Do interruptions to the continuity of methadone maintenance treatment in specialist addiction settings increase the risk of drug-related poisoning deaths? A retrospective cohort study (Q89605496) (← links)
- From restrictive to more liberal: variations in moratlity among patients in opioid maintenance treament over a 12-year period (Q92480461) (← links)
- Factors Associated with Compliance among Methadone Maintenance Treatment Transfers: Evidence from Audit Records at Clinics in Guangdong, China (Q92589725) (← links)
- Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada (Q93050783) (← links)